Search

Gary W. Counts

Examiner (ID: 5481, Phone: (571)272-0817 , Office: P/1678 )

Most Active Art Unit
1678
Art Unit(s)
1641, 1678, 1677
Total Applications
1282
Issued Applications
604
Pending Applications
186
Abandoned Applications
499

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19529524 [patent_doc_number] => 20240353426 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-24 [patent_title] => Methods for Diagnosing and Treating Ischemic Eye Disease [patent_app_type] => utility [patent_app_number] => 18/683069 [patent_app_country] => US [patent_app_date] => 2022-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30757 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18683069 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/683069
Methods for Diagnosing and Treating Ischemic Eye Disease Aug 10, 2022 Pending
Array ( [id] => 17991285 [patent_doc_number] => 20220357322 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-10 [patent_title] => METHODS AND MATERIALS FOR IDENTIFYING AND TREATING AUTOIMMUNE GFAP ASTROCYTOPATHY [patent_app_type] => utility [patent_app_number] => 17/870477 [patent_app_country] => US [patent_app_date] => 2022-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13469 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17870477 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/870477
Methods and materials for identifying and treating autoimmune GFAP astrocytopathy Jul 20, 2022 Issued
Array ( [id] => 18254846 [patent_doc_number] => 20230081885 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-16 [patent_title] => BIOMARKERS FOR DIAGNOSING IMPLANT RELATED RISK OF IMPLANT REVISION DUE TO ASEPTIC LOOSENING [patent_app_type] => utility [patent_app_number] => 17/812537 [patent_app_country] => US [patent_app_date] => 2022-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10664 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17812537 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/812537
Biomarkers for diagnosing implant related risk of implant revision due to aseptic loosening Jul 13, 2022 Issued
Array ( [id] => 17931102 [patent_doc_number] => 20220326227 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-13 [patent_title] => IMMUNOCHROMATOGRAPHY [patent_app_type] => utility [patent_app_number] => 17/851215 [patent_app_country] => US [patent_app_date] => 2022-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6711 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17851215 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/851215
IMMUNOCHROMATOGRAPHY Jun 27, 2022 Pending
Array ( [id] => 18308068 [patent_doc_number] => 20230111968 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-13 [patent_title] => Secreted P-glycoprotein is a Non-Invasive Biomarker of Chronic Rhinosinusitis [patent_app_type] => utility [patent_app_number] => 17/851613 [patent_app_country] => US [patent_app_date] => 2022-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17676 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17851613 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/851613
Secreted P-glycoprotein is a Non-Invasive Biomarker of Chronic Rhinosinusitis Jun 27, 2022 Abandoned
Array ( [id] => 19475016 [patent_doc_number] => 12105095 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-10-01 [patent_title] => Assay to detect and quantitate specific antibodies for various redox forms of HMGB1 [patent_app_type] => utility [patent_app_number] => 17/848804 [patent_app_country] => US [patent_app_date] => 2022-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 22 [patent_no_of_words] => 9844 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 188 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17848804 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/848804
Assay to detect and quantitate specific antibodies for various redox forms of HMGB1 Jun 23, 2022 Issued
Array ( [id] => 19362141 [patent_doc_number] => 20240264175 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-08 [patent_title] => METHOD FOR ASSESSING RISK OF HEMORRHAGIC STROKE USING SOLUBLE CLEC2 [patent_app_type] => utility [patent_app_number] => 18/565258 [patent_app_country] => US [patent_app_date] => 2022-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6305 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18565258 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/565258
METHOD FOR ASSESSING RISK OF HEMORRHAGIC STROKE USING SOLUBLE CLEC2 May 30, 2022 Pending
Array ( [id] => 19092053 [patent_doc_number] => 11953500 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-04-09 [patent_title] => Detection reagent and therapeutic target for B cell tumor after targeted therapy and related application [patent_app_type] => utility [patent_app_number] => 17/824162 [patent_app_country] => US [patent_app_date] => 2022-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10057 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 207 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17824162 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/824162
Detection reagent and therapeutic target for B cell tumor after targeted therapy and related application May 24, 2022 Issued
Array ( [id] => 17838955 [patent_doc_number] => 20220276260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-01 [patent_title] => GLUCURONYLATION AS A NEW ACIDIC POST-TRANSLATIONAL MODIFICATION ON THERAPEUTIC MONOCLONAL ANTIBODIES [patent_app_type] => utility [patent_app_number] => 17/745140 [patent_app_country] => US [patent_app_date] => 2022-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3576 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17745140 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/745140
GLUCURONYLATION AS A NEW ACIDIC POST-TRANSLATIONAL MODIFICATION ON THERAPEUTIC MONOCLONAL ANTIBODIES May 15, 2022 Abandoned
Array ( [id] => 19382307 [patent_doc_number] => 20240272177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-15 [patent_title] => sFRP4 AS BLOOD BIOMARKER FOR THE NON-INVASIVE DIAGNOSIS OF ADENOMYOSIS [patent_app_type] => utility [patent_app_number] => 18/561621 [patent_app_country] => US [patent_app_date] => 2022-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12640 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18561621 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/561621
sFRP4 AS BLOOD BIOMARKER FOR THE NON-INVASIVE DIAGNOSIS OF ADENOMYOSIS May 15, 2022 Pending
Array ( [id] => 19114051 [patent_doc_number] => 20240125801 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-18 [patent_title] => MARKER FOR DIAGNOSIS OF NONALCOHOLIC FATTY LIVER DISEASE [patent_app_type] => utility [patent_app_number] => 18/276218 [patent_app_country] => US [patent_app_date] => 2022-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9558 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18276218 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/276218
MARKER FOR DIAGNOSIS OF NONALCOHOLIC FATTY LIVER DISEASE May 12, 2022 Pending
Array ( [id] => 17838954 [patent_doc_number] => 20220276259 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-01 [patent_title] => METHODS FOR DIAGNOSING SYSTEMIC LUPUS ERYTHEMATOSUS [patent_app_type] => utility [patent_app_number] => 17/743289 [patent_app_country] => US [patent_app_date] => 2022-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18053 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17743289 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/743289
METHODS FOR DIAGNOSING SYSTEMIC LUPUS ERYTHEMATOSUS May 11, 2022 Abandoned
Array ( [id] => 17831488 [patent_doc_number] => 20220268792 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-25 [patent_title] => COMPOSITIONS AND METHODS FOR THE DETECTION OF HOST CELL PROTEINS [patent_app_type] => utility [patent_app_number] => 17/735555 [patent_app_country] => US [patent_app_date] => 2022-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22465 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17735555 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/735555
COMPOSITIONS AND METHODS FOR THE DETECTION OF HOST CELL PROTEINS May 2, 2022 Pending
Array ( [id] => 17831487 [patent_doc_number] => 20220268791 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-25 [patent_title] => COMPOSITIONS AND METHODS FOR THE DETECTION OF HOST CELL PROTEINS [patent_app_type] => utility [patent_app_number] => 17/735524 [patent_app_country] => US [patent_app_date] => 2022-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22453 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17735524 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/735524
Compositions and methods for the detection of host cell proteins May 2, 2022 Issued
Array ( [id] => 20454076 [patent_doc_number] => 12517128 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-01-06 [patent_title] => Sample collection and analysis [patent_app_type] => utility [patent_app_number] => 17/735836 [patent_app_country] => US [patent_app_date] => 2022-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 0 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 268 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17735836 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/735836
Sample collection and analysis May 2, 2022 Issued
Array ( [id] => 20069913 [patent_doc_number] => 20250208135 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-06-26 [patent_title] => Biomarkers for Neurodegenerative Disease [patent_app_type] => utility [patent_app_number] => 18/557941 [patent_app_country] => US [patent_app_date] => 2022-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16907 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18557941 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/557941
Biomarkers for Neurodegenerative Disease Apr 27, 2022 Pending
Array ( [id] => 19136461 [patent_doc_number] => 11971407 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-04-30 [patent_title] => Detection of anti-p53 antibodies [patent_app_type] => utility [patent_app_number] => 17/730403 [patent_app_country] => US [patent_app_date] => 2022-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5882 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17730403 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/730403
Detection of anti-p53 antibodies Apr 26, 2022 Issued
Array ( [id] => 17983869 [patent_doc_number] => 20220349905 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-03 [patent_title] => METHODS AND DEVICES FOR QUANTITATIVELY ESTIMATING SYNDECAN-1 [patent_app_type] => utility [patent_app_number] => 17/715294 [patent_app_country] => US [patent_app_date] => 2022-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3011 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17715294 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/715294
Methods and devices for quantitatively estimating syndecan-1 Apr 6, 2022 Issued
Array ( [id] => 19433866 [patent_doc_number] => 20240302364 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-12 [patent_title] => Compositions and Methods of Detecting Analytes [patent_app_type] => utility [patent_app_number] => 18/551159 [patent_app_country] => US [patent_app_date] => 2022-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13058 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18551159 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/551159
Compositions and Methods of Detecting Analytes Apr 2, 2022 Pending
Array ( [id] => 20220961 [patent_doc_number] => 20250283892 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-09-11 [patent_title] => DIAGNOSIS OF ALZHEIMER'S DISEASE BY DETECTING AUTO-ANTIBODIES AGAINST Y-BOX BINDING PROTEIN-1 (YB-1) [patent_app_type] => utility [patent_app_number] => 18/551454 [patent_app_country] => US [patent_app_date] => 2022-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2244 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18551454 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/551454
DIAGNOSIS OF ALZHEIMER'S DISEASE BY DETECTING AUTO-ANTIBODIES AGAINST Y-BOX BINDING PROTEIN-1 (YB-1) Mar 21, 2022 Pending
Menu